Navigation Links
Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
Date:9/6/2007

iate the TIME-1 trial at the end of 2007 or early 2008.

"Kosan's successful completion of both the Special Protocol Assessment process with the FDA and Scientific Advice from the EMEA for our TIME-1 trial provides us with a clear roadmap to registration in major countries around the world for this potentially important new treatment for patients with multiple myeloma," said Robert G. Johnson, Jr., M.D., Ph.D., Kosan's President and Chief Executive Officer. "We believe that Kosan's TIME program is the most advanced Hsp90 inhibitor clinical program in the industry, underscoring Kosan's leadership in this promising new class of anticancer therapies. We appreciate the widespread support we have received from the US and international myeloma clinician and patient communities."

About TIME

The TIME clinical program utilizes Kosan's improved, proprietary injectable suspension formulation of tanespimycin. The injectable suspension formulation is designed to provide important benefits, including improved patient safety, due to the elimination of Cremophor(R) and the associated need for steroid premedication to prevent hypersensitivity reactions. Tanespimycin injectable suspension also has a potentially enhanced intellectual property position and permits easier drug preparation and administration compared to the prior formulation.

The TIME-1 trial will be an open-label, randomized, multi-center trial conducted in the US and in Europe that is designed to enroll over 450 patients with relapse of multiple myeloma following a single prior course of treatment (first-relapse). The trial is designed to compare two groups: patients treated with bortezomib plus tanespimycin and patients treated with bortezomib alone. Tanespimycin will be administered at a dose of 340 mg/m2 and all patients will receive standard doses of bortezomib (1.3 mg/m2). TIME-1 is designed with a primary endpoint of progression-free survival. TIME-1 is designed to include an interim analys
'/>"/>

SOURCE Kosan Biosciences Incorporated
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90 Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory Breast and Ovarian Cancers at ASCO
2. Kosan Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Epothilone KOS-1584 at ASCO
3. Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing Promising Antitumor Activity in Multiple Myeloma at ASCO
4. Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO
5. Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR
6. Kosan Presents Preclinical Antitumor and Safety Data On Next-Generation Epothilone KOS-1803 at AACR
7. Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor Tanespimycin (KOS-953) at AACR
8. Kosan Announces Data Presentations at Upcoming AACR Annual Meeting
9. Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection
10. Protalix BioTherapeutics, Inc. Receives Approval from the FDA to Initiate a Phase III Clinical Trial of prGCD
11. DUSA Pharmaceuticals Receives Orphan Drug Desi gnation for Levulan PDT to Treat Esophage al Dysplasia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... KV Pharmaceutical Company ( KVa/KVb) today announced that on ... (the "Notice") executed by the Marc S. Hermelin Revocable ... that the Board of Directors of the Company (the ... written consent relating to the proposed appointment of John ... Ronald J. Kanterman,s departure (the "Director Appointment"). ,, As ...
(Date:12/15/2009)... Ever wonder what something looks like up ... of the Personal Scanning Electron Microscope (PSEM), kicked off ... send in samples to be scanned by one of ... scan range of 100nm to 5mm and an imaging ... into focus. In addition, ASPEX will not only scan ...
(Date:12/15/2009)... an opportune time to find the best plan at ... 15 Through the end of the year, ... decisions about their health coverage. This is when ... health benefits they will sign up and pay for ... critical part of this decision, says Independent Retail Pharmacist ...
Breaking Medicine Technology:KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 2KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 3KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 4KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 5KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 6KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 7ASPEX Kicks Off Free 'Send Us Your Sample' Microscopy Campaign 2Pharmacist Urges Nebraska Medicare Beneficiaries to Compare Prescription Plans 2Aptilon Announces Acquisition of Direct Medical Data LLC and BLM Incorporated and Concurrent Private Placements 57681 1Aptilon Announces Acquisition of Direct Medical Data LLC and BLM Incorporated and Concurrent Private Placements 57681 2Aptilon Announces Acquisition of Direct Medical Data LLC and BLM Incorporated and Concurrent Private Placements 57681 3Aptilon Announces Acquisition of Direct Medical Data LLC and BLM Incorporated and Concurrent Private Placements 57681 4Aptilon Announces Acquisition of Direct Medical Data LLC and BLM Incorporated and Concurrent Private Placements 57681 5Health Plans Reduce Administrative Expenses with HEALTHsuite 28R 29 from RAM Technologies Inc 57678 1Health Plans Reduce Administrative Expenses with HEALTHsuite 28R 29 from RAM Technologies Inc 57678 2With Alcohol Starting Young May Lead to Dependency 57676 1With Alcohol Starting Young May Lead to Dependency 57676 2
... studies presented at the American Urological Association,s (AUA) 104th ... prescribed to lower cholesterol--may benefit men with prostate cancer, ... key research studies highlighting these benefits will be presented ... Monday, April 27 from 9 to 10:30 a.m. ...
... April 27 As body mass increases, ... (UTI), according to Baltimore researchers. A new study, presented ... Urological Association (AUA), assesses and stratifies this risk.Researchers evaluated ... period (from 2002 through 2006) to identify whether obesity ...
Other Medicine Technology:New Body of Research Suggests Statin Use Benefits Multiple Areas of Urologic Health 2Obesity Associated With Higher Risk for Urinary Tract Infections 2
(Date:12/15/2009)... Dec. 15 Our Lady of Lourdes Health ... Jersey hospitals, has agreed to pay the United States ... Medicare, the Justice Department announced today. The two hospitals ... Camden, N.J., and Lourdes Medical Center of Burlington County ... defendant in a suit brought by a whistleblower, Tony ...
(Date:12/15/2009)... needed for protection, CDC says, , , TUESDAY, Dec. 15 ... swine flu vaccine have been recalled by manufacturer Sanofi ... health officials said Tuesday. , According to the U.S. ... testing of the vaccine for children aged 6 months ... lower than required potency levels. "This means that doses ...
(Date:12/15/2009)... Dec. 15 4R Systems, Inc., a ... solutions which help retailers significantly increase profits by ... announced today that The Vitamin Shoppe has been ... "4R,s store and DC inventory solutions have helped ... and in-stocks over the last two years," said ...
(Date:12/15/2009)... -- North American application activity for individually underwritten ... to the MIB Life Index(SM) . ... past three months have lifted year-to-date (YTD) figures ... flat at November,s close, -0.1%. "It is ... benefits available from life insurance," says Stacy Gill, ...
(Date:12/15/2009)... decade, the United Nations Foundation has led the fight ... World Malaria Report 2009 that the global strategies for ending malaria ... Health for the United Nations Foundation , ... Washington, ... United Nations Foundation has led the fight against malaria, ...
Breaking Medicine News(10 mins):Health News:Parent Company of Two New Jersey Hospitals to Pay U.S. $7.95 Million to Settle False Claims Act Allegations 2Health News:Large Recall of Children's Swine Flu Vaccine 2Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 2Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 3Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 4Health News:MIB Life Index Reports North American Life Insurance Activity Up 3.9% in November 2Health News:MIB Life Index Reports North American Life Insurance Activity Up 3.9% in November 3Health News:Statement by Dr. Daniel Carucci, Vice President for Global Health for the United Nations Foundation, on Progress Shown in World Malaria Report 2009 2
... 25 years of industry experience, COPPELL, Texas, ... a leading developer and provider of dietary,supplements and ... Marika,Berkley as the company,s vice president of global ... pleased to announce Marika,s addition to our,management team," ...
... 2008) -- An enzyme released by mast cells in the ... of airways that is a hallmark of asthma -- pointing ... , Reporting in the online edition of Proceedings of the ... College explains that during an immune response, mast cells release ...
... shows early promise for diagnosing, treating tumors , , ... not a particular cancer will be aggressive allows doctors ... found class of molecules called microRNAs may help doctors ... on a particular microRNA, designated miR-21, that may predict ...
... was also lower than researchers anticipated , , TUESDAY, Jan. ... the real-life effectiveness of two different drug-coated stents, Danish ... and a lower rate of problems than had been ... people who had these flexible tubes implanted to help ...
... Just in time for the Superbowl,NaturalNews.com has launched ... Blueberry battling it out against Junk Foods,running back ... the,performance-enhancing properties of superfoods in a fun, entertaining ... , The Super Foods team features Tom ...
... Ga., Jan. 29 Immucor, Inc. (Nasdaq:,BLUD), a ... blood transfusion industry, announced today that Ronny B. ... effective February 1, 2008. Mr.,Lancaster currently serves as ... Inc., and previously served as Senior Vice,President and ...
Other Medicine News:Health News:Mannatech Names New VP of Regulatory Affairs, Quality Assurance 2Health News:Mannatech Names New VP of Regulatory Affairs, Quality Assurance 3Health News:Lungs' mast cells could provide new treatment target for asthma, other respiratory disease 2Health News:Lungs' mast cells could provide new treatment target for asthma, other respiratory disease 3Health News:MicroRNAs May Predict Colon Cancer Prognosis 2Health News:MicroRNAs May Predict Colon Cancer Prognosis 3Health News:Study Finds Both Coated Stents Perform the Same 2Health News:Study Finds Both Coated Stents Perform the Same 3Health News:Super Food Bowl Animation From NaturalNews.com Teaches Kids to Avoid Junk Foods, Pursue Natural Nutrition 2Health News:Immucor, Inc. Adds Director to Board 2
... and economic issues of cerclage wiring, the ... maximize tension control while minimizing invasion of ... instrumentation with a simple technique. , ... for general orthopaedic trauma surgery involving: Olecranon ...
OmniAccess&trade Hip Retractor System sets a new standard in hip exposure. It provides constant, absolute exposure of the acetabulum during total hip arthroplasty and revision procedures....
... Many of DePuy's aggressive innovations have ... yet to be equalled. The AML ... stem to efficiently address and effectively meet ... hip arthroplasty. With greater than 15 ...
The Endotrac™ System includes an Obturator, Slotted Cannula, Synovial Elevator, Ligament Probe, Ligament Rasp, Blade Handle, two Retractors and sterilizable tray. The Endotrac&trade....
Medicine Products: